<?xml version="1.0" encoding="UTF-8"?>
<p class="p">The different tested
 <italic class="italic"> breu</italic> formulations significantly decreased the duration of the licking time in both phases of pain responses in the formalin-induced licking model. One possible explanation for this effect is that
 <italic class="italic"> breu</italic> may act by decreasing the release of inflammatory mediators or exert direct effects on different receptors present in the paw, such as bradykinin, serotonin, or opioid receptors, thus reducing the licking response.
</p>
